Open Beta
MetriLume

US marketsHCAT

SEC-sourced researchBeta

HCAT

Health Catalyst, Inc.

Company comparison ↗

Data passport

CIK
0001636422
Exchange
Nasdaq
Business activity
— · SIC 7370
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 295,938,000.0000 USD; December 2024: 306,584,000.0000 USD; December 2025: 311,136,000.0000 USD311.1M USD0 USD0December 2023December 2024December 2025
HCAT · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023295,938,000.0000Mar 12, 2026
December 2024306,584,000.0000Mar 12, 2026
December 2025311,136,000.0000Mar 12, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025311,136,000.0000-177,974,000.0000731,000.0000502,643,000.0000256,863,000.0000Mar 12, 2026
December 2024306,584,000.0000-69,502,000.000014,559,000.0000858,929,000.0000493,722,000.0000Mar 12, 2026
December 2023295,938,000.0000-118,147,000.0000-33,080,000.0000——Mar 12, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$311.14MDecember 2025Mar 12, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$306.58MDecember 2024Mar 12, 202610-K
Net incomeNetIncomeLoss-$177.97MDecember 2025Mar 12, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$731KDecember 2025Mar 12, 202610-K
Total assetsAssets$502.64MDecember 2025Mar 12, 202610-K
Total liabilitiesLiabilities$256.86MDecember 2025Mar 12, 202610-K

New filings

Explore methodology ↗